Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine

被引:77
作者
Munro, J
Matthiasson, P
Osborne, S
Travis, M
Purcell, S
Cobb, AM
Launer, M
Beer, MD
Kerwin, R
机构
[1] Inst Psychiat, Div Psychol Med, Sect Clin Neuropharmacol, London SE5 8AF, England
[2] Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London, England
[3] Royal London Hosp St Clements, Dept Psychiat, London, England
[4] Burnley Gen Hosp, Lamont Clin, Burnley, Lancs, England
[5] Oxleas NHS Trus, Bracton Ctr, Dartford, Kent, England
关键词
schizophrenia; treatment resistant; clozapine; amisulpride; augmentation;
D O I
10.1111/j.1600-0447.2004.00356.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Treatment options are very limited for individuals with schizophrenia resistant to clozapine. We tested the hypothesis that amisulpride augmentation would lead to an improvement in these patients. Method: This was an open non-randomized study. Thirty-three patients with sub-optimal response to clozapine were commenced on amisulpride in addition to clozapine. Clinical status was evaluated at baseline, 3 and 6 months using the Positive And Negative Syndrome Scale (PANSS), Scale for the Assessment of Negative Symptoms (SANS), Global Assessment Scale (GAS), Calgary Depression Scale, Calgary Anxiety Scale and various side effect rating scales. Results: Twenty-eight subjects completed 6 months treatment on clozapine and amisulpride. There was a statistically significant improvement in the mean scores for PANSS, SANS and GAS at follow-up and no significant changes in side effect ratings. Conclusion: Co-administration of amisulpride, in a group of patients partially or non-responsive to clozapine, may lead to a substantial improvement in positive and negative symptoms, without worsening the side effect burden.
引用
收藏
页码:292 / 298
页数:7
相关论文
共 50 条
[21]   Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review [J].
Sommer, Iris E. ;
Begemann, Marieke J. H. ;
Temmerman, Anke ;
Leucht, Stefan .
SCHIZOPHRENIA BULLETIN, 2012, 38 (05) :1003-1011
[22]   Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor or Partial Response to Clozapine: A Retrospective Study [J].
Kisa, Cebrail ;
Akdag, Hatice Alkan ;
Aydemir, Cigdem ;
Goka, Erol .
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2010, 47 (04) :302-306
[23]   Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study [J].
Stryjer, R ;
Strous, R ;
Bar, F ;
Shaked, G ;
Shiloh, R ;
Rozencwaig, S ;
Grupper, D ;
Buchman, N ;
Kotler, M ;
Rabey, JM ;
Weizman, A .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 (05) :343-346
[24]   Augmentation of Clozapine With Agomelatine in Partial-Responder Schizophrenia A 16-Week, Open-Label, Uncontrolled Pilot Study [J].
Bruno, Antonio ;
Zoccali, Rocco A. ;
Abenavoli, Elisabetta ;
Pandolfo, Gianluca ;
Scimeca, Giuseppe ;
Spina, Edoardo ;
Muscatello, Maria Rosaria Anna .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (04) :491-494
[25]   Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial [J].
Zhu, Ming-Huan ;
Liu, Zhen-Jing ;
Hu, Qiong-Yue ;
Yang, Jia-Yu ;
Jin, Ying ;
Zhu, Na ;
Huang, Ying ;
Shi, Dian-Hong ;
Liu, Min-Jia ;
Tan, Hong-Yang ;
Zhao, Lei ;
Lv, Qin-Yu ;
Yi, Zheng-Hui ;
Wu, Feng-Chun ;
Li, Ze-Zhi .
MILITARY MEDICAL RESEARCH, 2022, 9 (01)
[26]   Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial [J].
Ming-Huan Zhu ;
Zhen-Jing Liu ;
Qiong-Yue Hu ;
Jia-Yu Yang ;
Ying Jin ;
Na Zhu ;
Ying Huang ;
Dian-Hong Shi ;
Min-Jia Liu ;
Hong-Yang Tan ;
Lei Zhao ;
Qin-Yu Lv ;
Zheng-Hui Yi ;
Feng-Chun Wu ;
Ze-Zhi Li .
Military Medical Research, 9
[27]   Augmentation Strategies for Partial or Non-responders to Clozapine in Patients with Schizophrenia: A Bayesian Network Meta-analysis of Randomized Controlled Trials [J].
Mishra, Archana ;
Maiti, Rituparna ;
Mishra, Biswa Ranjan ;
Srinivasan, Anand .
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (02) :232-252
[28]   Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series [J].
Kalenderoglu, Aysun ;
Celik, Mustafa .
TURK PSIKIYATRI DERGISI, 2016, 27 (01) :57-62
[29]   Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study [J].
Kreinin, A ;
Novitski, D ;
Weizman, A .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (02) :99-103
[30]   Augmentation Strategies in Patients with Schizophrenia Who Show Partial Response to Clozapine Treatment [J].
Vayisoglu, Sefa ;
Anil Yagcioglu, Elif .
TURK PSIKIYATRI DERGISI, 2014, 25 (03) :201-211